MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2024 International Congress
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search

Articles tagged "Non-motor Scales"

  • 2019 International Congress

    The influence of physical activities on cognition in small group of Parkinson’s Disease patients

    J. Silva, M. Pereira, L. Piovesara, P. Azevedo, F. Cendes, A. D'Abreu, R. Guimarães (Campinas, Brazil)

    Objective: To assess the relation between cognitive performance and physical exercise in Parkinson's Disease patient. Background: Cognitive deficit is a common non-motor symptom in PD,…
  • 2019 International Congress

    Non motor fluctuations in Parkinson’s disease: Findings from a Tunisian cohort

    M. Ben Djebara, K. Laabidi, A. Nasri, A. Rekik, S. Mrabet, A. Gargouri, I. Kacem, R. Gouider (Tunis, Tunisia)

    Objective: To evaluate the frequency of non motor fluctuations (NMF) in Parkinson's disease (PD), their correlation with motor complications and their impact on the quality…
  • 2019 International Congress

    Relationship between striatal dopamine depletion and various non-motor symptoms in non-demented patients with Parkinson’s disease: a pilot study

    JY. Lee, H. Ju, K. Im, MY. Ahn, KY. Kwon (Seoul, Republic of Korea)

    Objective: We aimed to investigate associations of striatal dopamine uptake and various non-motor symptoms in non-demented patients with Parkinson’s disease (PD). Background: Dopamine transporter (DAT)…
  • 2019 International Congress

    Effect of opicapone in Parkinson’s disease patients with ‘early’ motor fluctuations: Parkinson’s Disease Questionnaire (PDQ-39) analysis from the BIPARK-I double-blind experience

    J. Rocha, E. Tolosa, J. Ferreira, A. Lees, O. Rascol, W. Poewe, A. Santos, D. Magalhães, P. Soares-da-Silva (Coronado, Portugal)

    Objective: To evaluate the impact of opicapone (OPC) on PDQ-39 in levodopa-treated Parkinson’s Disease (PD) patients with ‘early’ motor fluctuations. Background: OPC, a once-daily COMT…
  • 2019 International Congress

    African American patients with Parkinson’s disease: A hospital-based study compared to Caucasian patients

    T. Xie, D. Lee, M. Padmanaban, H. Yu, W. Kang, J. Johnson, J. Alshaikh, C. Yuen, M. Burns, F. Qian, B. Chiu (Chicago, IL, USA)

    Objective: To characterize the demographic, socioeconomic, clinical and healthcare features of African American (AA) patients with Parkinson’s disease (PD) compared to Caucasian PD patients in…
  • 2019 International Congress

    Motor and non-motor symptoms related to sleep disturbances in Parkinson’s disease

    D. van Wamelen, V. Leta, A. Podlewska, Y. Wan, A. Sauerbier, A. Rizos, P. Martinez-Martin, K. Chaudhuri (Madrid, Spain)

    Objective: To assess which (non-)motor symptoms are associated with the longitudinal development of sleep disturbances, one of the major non-motor symptoms (NMS) in Parkinson’s disease…
  • 2019 International Congress

    (Not) sleeping with the enemy: Cognitive correlates of nocturnal sleep disturbances in Parkinson’s disease

    S. Castillo-Torres, C. Cerda-Contreras, D. Roque-Martínez, D. Díaz-Pérez, X. Ortiz-Jiménez, B. Chávez-Luévanos, I. Estrada-Bellmann (Monterrey, Mexico)

    Objective: To evaluate cognitive correlates of nocturnal sleep dysfunction in patients with idiopathic Parkinson’s disease (PD). Background: Sleep disturbances are among the most troublesome and…
  • 2019 International Congress

    Mindfulness Based Stress Reduction in People with Parkinson’s Disease and their Carepartners

    D. Shah, S. Mantri, J. Cooney, A. Allen, K. Durham, J. Brantley, R. Vereen, P. Hickey, B. Scott (Durham, NC, USA)

    Objective: To assess the feasibility and impact of mindfulness based stress reduction (MBSR) on people with Parkinson’s disease (PD) and their carepartners. Background: Non-motor symptoms…
  • 2019 International Congress

    Somatization disorder (SD) and Parkinson’s Disease (PD) in Mexican population

    M. Rodriguez-Violante, A. Cervantes-Arriaga, A. Polo-Morales, A. Alcocer-Salas (Ciudad de México, Mexico)

    Objective: Identify, in Mexican patients with PD, the prevalence of SD as well as its impact on cognitive and motor impairment. Background: SD refers to…
  • 2019 International Congress

    Discriminative power of different olfactory domains in Parkinson’s disease

    YW. Zhao, RC. He, JX. Yang, Y. Zhang, XT. Zhou, XX. Zhou, LX. Qin, Y. Tian, ZQ. Wang, QY. Sun, Q. Xu, JC. Li, JF. Guo, XX. Yan, BS. Tang (Changsha, China)

    Objective: The aim of this study was to evaluate which kind of olfactory domain was the best in discriminating PD patients from controls, and to…
  • « Previous Page
  • 1
  • …
  • 26
  • 27
  • 28
  • 29
  • 30
  • …
  • 51
  • Next Page »

Most Viewed Abstracts

  • This Week
  • This Month
  • All Time
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Life expectancy with and without Parkinson’s disease in the general population
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • An atypical and interesting feature of Parkinson´s disease
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Effect of marijuana on Essential Tremor: A case report
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Estimation of the 2020 Global Population of Parkinson’s Disease (PD)
  • Patients with Essential Tremor Live Longer than their Relatives
  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2025 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley